Literature DB >> 23608673

Differences in HIV-1 viral loads between male and female antiretroviral-untreated Mexican patients.

Paola Ballesteros-Zebadúa1, Carlos Villarreal, Germinal Cocho, Leonor Huerta, José Luis Estrada.   

Abstract

BACKGROUND AND AIMS: HIV-1 viral load is used to monitor AIDS progression and effect of antiretroviral therapy (ART). Several reports have indicated that the HIV-1 viral load of infected individuals is lower in females than in males. There are no reports exploring this issue in the Mexican population. We analyzed the relationship between sex and viral load in Mexican patients differing in CD4 T-cell count, age and treatment status.
METHODS: A retrospective study was performed in 3949 male and 696 female HIV-1-infected individuals. Statistical distributions were compared using the Mann-Whitney U nonparametric test.
RESULTS: Among the antiretroviral-untreated group, females had a significantly lower viral load than males (0.52 female/male median viral load ratio, p = 0.008). When classified according to different ranges of CD4⁺ T cell counts, females had consistently lower viral loads than males, although statistical significance was achieved only for the group in the range of 201-350 (p = 0.014). Patients with the lowest CD4⁺ T-cell counts showed similar viral loads for both sexes. No differences were observed in the ART group.
CONCLUSIONS: This study demonstrates a baseline difference in viral load between male and female ART-untreated Mexican patients. The overall tendency indicating a lower viral load in females in the same ranges of CD4⁺ T-cell counts than males, suggests that the lower viral load in females is not indicative of a lower risk of developing AIDS. These observations suggest a significant influence of sex on viral dynamics and immune response despite variations in demographic factors.
Copyright © 2013 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23608673     DOI: 10.1016/j.arcmed.2013.04.003

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  6 in total

Review 1.  Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic review.

Authors:  Jessica L Castilho; Vlada V Melekhin; Timothy R Sterling
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-07       Impact factor: 2.205

2.  Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam.

Authors:  Suresh Rangarajan; J Colby Donn; Le Truong Giang; Duc Duong Bui; Huu Hung Nguyen; Plui Broh Tou; Tran Tri Danh; Ngoc Bao Chau Tran; Duc Anh Nguyen; Bao Tram Hoang Nguyen; Vu Tuyet Nga Doan; Nhat Quang Nguyen; Van Phuoc Pham; Duc Giang Dao; Mario Chen; Yanwu Zeng; Thi Thu Van Tieu; My Hanh Tran; Thi Hoa Le; Xuan Chien Hoang; Gary West
Journal:  J Virus Erad       Date:  2016-04-01

3.  Factors associated with HIV RNA viral loads in ART-naïve patients: implications for treatment as prevention in concentrated epidemics.

Authors:  Suresh Rangarajan; Donn J Colby; Giang Le Truong; Hung Nguyen Huu; Van Tieu Thi Thu; Binh Luong Quoc; Tou Plui Broh; Danh Tran Tri; Dao Duc Giang; Mario Chen; Yanwu Zeng; Gary West
Journal:  J Virus Erad       Date:  2016-01-01

4.  HIV-1 Viral Loads Are Not Elevated in Individuals Co-infected With Schistosoma spp. After Adjustment for Duration of HIV-1 Infection.

Authors:  Soledad Colombe; Paul L A M Corstjens; Claudia J de Dood; Donald Miyaye; Ruth G Magawa; Julius Mngara; Samuel E Kalluvya; Lisette van Lieshout; Govert J van Dam; Jennifer A Downs
Journal:  Front Immunol       Date:  2018-09-06       Impact factor: 7.561

5.  Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon.

Authors:  Henry D Meriki; Kukwah A Tufon; Mbunkah H Afegenwi; Bernard A Nyindem; Pascal N Atanga; Damian N Anong; Fidelis Cho-Ngwa; Theresa Nkuo-Akenji
Journal:  Infect Dis Poverty       Date:  2014-01-30       Impact factor: 4.520

6.  Time to viral load suppression and its associated factors in cohort of patients taking antiretroviral treatment in East Shewa zone, Oromiya, Ethiopia, 2018.

Authors:  Jemal Hassen Ali; Tewodros Getinet Yirtaw
Journal:  BMC Infect Dis       Date:  2019-12-27       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.